Test Your Understanding – Hemostasis

Prev
 1 / 13 
Next
Prev
 1 / 13 
Next

Learning objectives

After completing this quiz, the learner should be able to:

  • distinguish between cascade vs cell-based models
  • interpret bleeding timing as a diagnostic signal
  • recognize limitations of PT/aPTT
  • map clinical phenotype → layer of hemostasis
  • identify conditions with normal labs but abnormal bleeding (e.g., FXIII, fibrinolysis)
  • apply threshold biology to clinical reasoning

A patient develops immediate mucosal bleeding after dental extraction. Which layer of hemostasis is most likely impaired?

a
Initiation/amplification
Immediate bleeding at the time of challenge reflects failure of early hemostasis, including platelet function and von Willebrand factor, corresponding to initiation and amplification.
b
Stabilization
Stabilization defects (e.g., factor XIII deficiency) cause delayed bleeding, not immediate bleeding.
c
Fibrin formation
Fibrin defects typically produce severe bleeding with abnormal PT/APTT, not isolated mucosal bleeding at onset.
d
Fibrinolysis
Fibrinolytic disorders lead to re-bleeding after initial clot formation, not immediate bleeding.

A patient has delayed bleeding 24 hours after minor surgery with normal PT, APTT, and fibrinogen. What is the most likely mechanism?

a
Defective platelet adhesion
Platelet disorders cause immediate bleeding, not delayed bleeding.
b
Impaired thrombin generation
This would typically prolong PT and/or APTT, which are normal here.
c
Excessive fibrin formation
This is not a recognized mechanism of bleeding.
d
Failure of clot structural reinforcement
Classic for factor XIII deficiency: the clot forms normally but lacks stability, leading to delayed bleeding.

Which statement best describes what PT and APTT measure?

a
Platelet activation and aggregation
These are not assessed by PT/APTT, which use platelet-poor plasma.
b
Time to fibrin formation in a reconstructed plasma system
PT and APTT measure time to fibrin formation under artificial conditions, reflecting thrombin generation in vitro.
c
Clot structural integrity
These tests do not assess clot stability or crosslinking (e.g., factor XIII function).
d
Fibrinolytic activity
Fibrinolysis is not evaluated by PT/APTT.

A patient has prolonged APTT with variable, procedure-dependent bleeding that differs by tissue type. Which deficiency is most consistent?

a
Factor XI
Factor XI deficiency shows poor correlation between factor level and bleeding, with variable, tissue-specific, and procedure-dependent bleeding.
b
Factor XIII
Factor XIII deficiency presents with normal PT/APTT and delayed bleeding.
c
Fibrinogen
Fibrinogen deficiency causes severe bleeding with abnormal PT/APTT, not variable, mild bleeding.
d
Factor X
Factor X deficiency typically causes more consistent bleeding and affects both PT and APTT.

Among the following, which single factor is most strongly associated with a consistent relationship between activity level and bleeding severity?

a
Factor VII
Factor VII shows weak correlation between activity level and clinical phenotype.
b
Factor XI
Factor XI deficiency has highly variable bleeding, poorly predicted by factor level.
c
Factor XIII
Factor XIII shows a strong correlation between activity level and bleeding severity, reflecting its role in clot stability.
d
Factor V
Factor V does not demonstrate as strong or consistent a relationship as structural factors like FXIII.

A patient is found to have a factor VII activity level of 15% with a markedly prolonged PT. They report no history of bleeding, even with prior surgeries. What best explains this finding?

a
PT does not measure factor VII activity
PT is highly sensitive to factor VII levels and is often prolonged in deficiency.
b
Factor VII deficiency affects clot stability rather than formation
Factor VII functions in initiation, not stabilization.
c
Factor VII operates early in hemostasis and downstream processes can compensate
Initiation generates a signal, but propagation and fibrin formation may compensate, leading to minimal clinical bleeding despite abnormal PT.
d
ibrinolysis is increased, masking bleeding risk
There is no evidence that increased fibrinolysis explains this pattern.

Sort each condition by layer of hemostasis

factor VII deficiency
von Willebrand disease
factor XIII deficiency
factor XI deficiency
Initiation / amplification:
Propagation:
Stabilization:

Match the clinical pattern to the mechanism

severe bleeding from birth with abnormal PT/APTT
immediate mucosal bleeding at time of challenge
delayed bleeding with normal PT/APTT
stabilization or fibrinolysis defect
initiation/amplification defect
fibrin deficiency
Correct! Sorry, Incorrect.

Closing Note

Not all abnormalities bleed. Not all normal tests reassure.

Prev
 1 / 13 
Next